Sign in
4

Changes in Ownership

BIOLARGO, INC. Filed Acc 0001437749-24-021196

Options or other derivatives

  • Chief Financial Officer acquired 700,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

DARGAN CHARLES K · Chief Financial Officer

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-06-23 Grant or award : show line 1 in the form Option to purchase common stock +700,000 4,325,786 D
Loading xslF345X05/rdgdoc.xml…